Prokaryotic cell expression of the surface antigen 1 gene from GJS strain of Toxoplasma gondii and its antigenicity analysis

Li-yan CAO,De-lin ZHANG,Yan-li ZHANG,Yong LU,Zhi-jie CAI,Yan-hua WANG,Jin-jun ZHAO
DOI: https://doi.org/10.3969/j.issn.1002-2694.2009.08.024
2009-01-01
Abstract:To construct recombinant plasmid DNA encoding I gene from GJS strain of Toxoplasma gondii(SAG1) and investigate the protective immunity induced by SAG1 protein vaccine. One pair of specific primers based on the sequnces of the surface antigen gene of T. gondii RH strain was designed. SAG1 was obtained through PCR,cloned into PMD-18T vector and sequencing; and was subcloned into the vector PET-30a,its expression was induced by IPTG; Purified and refolded SAG1 (rSAG1) was used to immunize mice and to detect IgG antibodies by ELISA. All mice were challenged with highly virulent tachyzoites to test the protective immunity. Homology analysis showed that the ORF of nucleotide sequences and amino acid sequences of SAG1 shared 99% and 97% identity with those of the published T. gondii SAG1 sequence (S76248); The expressed product existed in a form of inclusion body and could be recognized by the goat serum against T. gondii; The SAG1 protein vaccine could induce high titer of anti-SAG1 antibodies in immunized mice; The protective trial proved that there was no significant difference between control group and experimental group though the survival time of mice from experimental group had been prolonged. It is evident that the expression plasmids containing the gene fragment enconding SAG1 surface antigen from T. gondii have been successfully constructed; bot protective immunity effects of SAG1 protein vaccine to mice was not strong.
What problem does this paper attempt to address?